As shown in Figure 3k, G5‐CHC‐R+US treated group demonstrated significantly up‐regulated expression of the CRT and high mobility group box 1 (HMGB1) in tumor tissues, suggesting higher ICD‐inducing capacity. The gene discussed is HMGB1; the disease is neoplasm.